Small molecule inducers of angiogenesis for tissue engineering.

Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia 22908, USA.
Tissue Engineering (Impact Factor: 4.25). 08/2006; 12(7):1903-13. DOI: 10.1089/ten.2006.12.1903
Source: PubMed

ABSTRACT Engineering of implantable tissues requires rapid induction of angiogenesis to meet the significant oxygen and nutrient demands of cells during tissue repair. To this end, our laboratories have utilized medicinal chemistry to synthesize non-peptide-based inducers of angiogenesis to aid tissue engineering. In this study, we describe the evaluation of SC-3-149, a small molecule compound with proliferative effects on vascular endothelial cells. Specifically, exogenous exposure of SC-3-149 induced an 18-fold increase in proliferation of human microvascular endothelial cells in vitro at low micromolar potency by day 14 in culture. Moreover, SC-3-149 significantly increased the formation of endothelial cord and tubelike structures in vitro, and improved endothelial scratch wound healing within 24 h. SC-3-149 also significantly inhibited vascular endothelial cell death owing to serum deprivation and high acidity (pH 6). Concurrent incubation of SC-3-149 with vascular endothelial growth factor increased cell survivability under serum-deprived conditions by an additional 7%. In addition, in vivo injection of SC-3-149 into the rat mesentery produced qualitative increases in microvessel length density. Taken together, our studies suggest that SC-3-149 and its analogs may serve as promising new angiogenic agents for targeted drug delivery and therapeutic angiogenesis in tissue engineering.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Musculoskeletal regenerative engineering approach using small bioactive molecules in conjunction with advanced materials has emerged as a highly promising strategy for musculoskeletal repair and regeneration. Advanced biomaterials technologies have revealed nanofiber-based scaffolds for musculoskeletal tissue engineering as vehicles for the controlled delivery of small molecule drugs. This review article highlights recent advances in nanofiber-based delivery of small molecules for musculoskeletal regenerative engineering. The article concludes with perspectives on the challenges and future directions.
    Nanomedicine : nanotechnology, biology, and medicine. 06/2014;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Stimulation of bone regeneration using growth factors is a promising approach for musculoskeletal regenerative engineering. Common limitations with protein growth factors are high manufacturing costs, protein instability, contamination issues, and unwanted immunogenic responses of the host. New strategies for bone regeneration that obviate these problems can have a significant impact on the treatment of skeletal injury and diseases. Over the past decade, a large number of small molecules with the potential of regenerating skeletal tissue have been reported in the literature. Here, we review this literature, paying specific attention to the prospects for small molecule-based bone-regenerative engineering. We also review the preclinical study of small molecules associated with bone regeneration.
    Drug discovery today 01/2014; · 6.63 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: We previously reported a class of designer self-assembling peptide nanofiber scaffolds as a unique biological material for diverse applications including 3-D tissue cell culture, slow drug release, regenerative medicine, and tissue engineering. One of these peptide scaffolds, RADA16-I has been used in bone, cartilage, and neural regeneration studies that have shown great promises. We here report the development of two new functionalized self-assembling peptide nanofiber scaffolds designed specifically for angiogenesis study through directly coupling pure RADA16-I with short biologically angiogenic motifs. Angiogenesis is very important in regenerative medicine. An adequate blood vessel supply to the newly formed tissue and within the transplanted scaffold is essential in determining the success of new tissue regeneration. In our study, two designer functionalized peptides, KLT, Ac–(RADA)4G4KLTWQELYQLKYKGI–CONH2 and PRG, Ac–(RADA)4GPRGDSGYRGDS–CONH2 significantly enhanced endothelial cell survival, proliferation, migration, and morphological tubulogenesis compared with unmodified RADA16-I scaffold. We also showed in our clear-boundary sandwich culture without adding extract soluble growth factors that cells migrated uni-directionally from RADA16-I toward the functionalized scaffolds but not the reverse. Our results suggest that the functionalized designer peptide scaffolds will not only have great promise for promoting endothelial cell growth, migration, and tubulogenesis, but also may have widely potential applications for diverse tissue engineering and tissues regeneration.
    Soft Matter 01/2008; 4(12). · 4.15 Impact Factor